학술논문
Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: “APRI c’est fini ?”
Document Type
Article
Author
Source
In Clinics and Research in Hepatology and Gastroenterology September 2014 38(4):432-439
Subject
Language
ISSN
2210-7401